| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2022-12-08 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | $20.00M | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $29.96M | $22.67M | $16.14M | $8.22M | – | $1.35M |
| R&D | $16.26M | $11.29M | $8.74M | $4.20M | – | $126.53K |
| SG&A | $13.70M | $11.38M | $7.41M | $4.02M | – | $1.23M |
| Operating Income | -$29.96M | -$22.67M | -$16.14M | -$8.22M | – | -$1.35M |
| Interest Expense | – | – | – | $497.00 | – | $179.85K |
| Tax Expense | $37.72K | $41.04K | $26.41K | $10.27K | – | $6.01K |
| Net Income | -$29.44M | -$21.61M | -$15.43M | -$8.23M | – | -$24.38M |
| EPS (basic) | -0.8900 | -0.7600 | -0.8900 | -0.5900 | – | -6.6400 |
| EPS (diluted) | -0.8900 | -0.7600 | -0.8900 | -0.5900 | – | – |
| Shares (diluted) | $32.97M | $28.29M | $17.34M | $13.89M | – | – |